+
Open data
-
Basic information
| Entry | ![]() | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Title | Prefusion stabilized spike glycoprotein of equine coronavirus. | |||||||||
Map data | EM map of the equine coronavirus spike glycoprotein. | |||||||||
Sample |
| |||||||||
Keywords | fusion glycoprotein / membrane protein / viral protein | |||||||||
| Biological species | Equine coronavirus | |||||||||
| Method | single particle reconstruction / cryo EM / Resolution: 2.76 Å | |||||||||
Authors | Melchers JM / Hulswit RJG / Hurdiss DL | |||||||||
| Funding support | Netherlands, 1 items
| |||||||||
Citation | Journal: PLoS Pathog / Year: 2026Title: AI-guided prefusion stabilization of the human coronavirus OC43 spike protein enables universal embecovirus antigen design. Authors: Jelle M Melchers / Jarek Juraszek / Ruben J G Hulswit / Daan van Overveld / Lam Le / Frank J M van Kuppeveld / Daniel L Hurdiss / Berend-Jan Bosch / Johannes P M Langedijk / Mark J G Bakkers / ![]() Abstract: The continued threat of zoonotic coronavirus spillovers underscores the need for cross-species applicable vaccine design strategies. The genus Embecovirus includes human coronaviruses OC43 and HKU1 ...The continued threat of zoonotic coronavirus spillovers underscores the need for cross-species applicable vaccine design strategies. The genus Embecovirus includes human coronaviruses OC43 and HKU1 as well as relevant veterinary pathogens. The coronavirus spike (S) fusion glycoprotein, key to viral entry and protective immunity, is inherently metastable, complicating vaccine development. Using the ReCaP AI tool, we stabilized the prefusion conformation of OC43 S through rationally combined amino acid substitutions, resulting in markedly enhanced expression and thermal stability. The substitutions were transferable to equine coronavirus (ECoV) S and HKU1. Cryo-EM structures of stabilized OC43 and ECoV S revealed that stabilization was achieved by arresting the release of the fusion peptide and keeping the S1B receptor binding domain in the 'down' state by improving the complex polar interactions of neighboring S1B domains and the bound free fatty acid at the interprotomer S1B interface. This work provides the first ECoV S structure and a broadly applicable framework for engineering stabilized Embecovirus S antigens. | |||||||||
| History |
|
-
Structure visualization
| Supplemental images |
|---|
-
Downloads & links
-EMDB archive
| Map data | emd_53687.map.gz | 9.4 MB | EMDB map data format | |
|---|---|---|---|---|
| Header (meta data) | emd-53687-v30.xml emd-53687.xml | 25.4 KB 25.4 KB | Display Display | EMDB header |
| FSC (resolution estimation) | emd_53687_fsc.xml | 11.9 KB | Display | FSC data file |
| Images | emd_53687.png | 81.3 KB | ||
| Filedesc metadata | emd-53687.cif.gz | 7.7 KB | ||
| Others | emd_53687_half_map_1.map.gz emd_53687_half_map_2.map.gz | 165 MB 165 MB | ||
| Archive directory | http://ftp.pdbj.org/pub/emdb/structures/EMD-53687 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-53687 | HTTPS FTP |
-Related structure data
-
Links
| EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
|---|
-
Map
| File | Download / File: emd_53687.map.gz / Format: CCP4 / Size: 178 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | EM map of the equine coronavirus spike glycoprotein. | ||||||||||||||||||||||||||||||||||||
| Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
| Voxel size | X=Y=Z: 0.836 Å | ||||||||||||||||||||||||||||||||||||
| Density |
| ||||||||||||||||||||||||||||||||||||
| Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
| Details | EMDB XML:
|
-Supplemental data
-Half map: Half map of equine coronavirus spike glycoprotein.
| File | emd_53687_half_map_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | Half map of equine coronavirus spike glycoprotein. | ||||||||||||
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Half map: Half map of equine coronavirus spike glycoprotein.
| File | emd_53687_half_map_2.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | Half map of equine coronavirus spike glycoprotein. | ||||||||||||
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-
Sample components
-Entire : Trimeric spike glycoprotein
| Entire | Name: Trimeric spike glycoprotein |
|---|---|
| Components |
|
-Supramolecule #1: Trimeric spike glycoprotein
| Supramolecule | Name: Trimeric spike glycoprotein / type: complex / ID: 1 / Parent: 0 / Macromolecule list: #1 |
|---|---|
| Source (natural) | Organism: Equine coronavirus / Location in cell: membrane |
| Molecular weight | Theoretical: 435 KDa |
-Macromolecule #1: Spike glycoprotein
| Macromolecule | Name: Spike glycoprotein / type: protein_or_peptide / ID: 1 / Number of copies: 3 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Equine coronavirus |
| Molecular weight | Theoretical: 143.631375 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: MVLLLLFFLP TAFAVVGDVK CTTIGVNDVN TGAPVISTET VDVTNGLGTY YVLDRVYLNT TLLLNGYYPT SGANYRNLAL KASELLSTL WYKPPFLSEF NDGVFAKVKN TKVTKNGIVY SEFPTMVIGT TFVNTSYTVV VQPRTTVVNS KLQGLLEITI C QYSMCEYP ...String: MVLLLLFFLP TAFAVVGDVK CTTIGVNDVN TGAPVISTET VDVTNGLGTY YVLDRVYLNT TLLLNGYYPT SGANYRNLAL KASELLSTL WYKPPFLSEF NDGVFAKVKN TKVTKNGIVY SEFPTMVIGT TFVNTSYTVV VQPRTTVVNS KLQGLLEITI C QYSMCEYP NTVCNSGIGS PRKELWHYEK AVASCLYRRN FTYDVNSDWL YFHFYQQGGT FYAYYTDSGF ITTFLFNIYL GT SLSHYYV MPLSCSGKLD LQYWVTPLTN RQFLLVFNQD GIIYNAVDCA SDYMSEIKCK TQNVKPSTGV YDLTGYTVQP IAD VYRRIP NLPDCNMEDW LSAPTVASPL NWERRTFSNC NFNMSSLLSF IQADSFSCSN IDAAKLYGMC FGSVTIDKFA IPNS RKVDL QLGNRGYLQR FNYRIDTTAT SCQLYYSLGA DNVTVTRSNP SAWNRRYGFN DTMFKPQPAG FFTNHDVVYS KQCFK VPNT YCPCKNNGAT CVGNGVSAGV SGTTTGSGTC PVGTSYRTCF NPIQCACTCD PEPINAILTS GPRACPQVKS LVGLGE HCS GLGIHEDFCG GSPCSCPANA FMAWSVDSCL QDGRCNIFSN LILNGVNSGA TCSTDLQRSN TEIVVGVCVK YDLYGIT GQ GIFIEVNATY YNSWQNLLYD SNGNLYGFRD YLTNRTFMIR SCYSGRVSAA YHSDASEPAL LYRNLKCNYV FNNTIARE G NPINYFDSYL GCIVNADNST SSVVDTCVLT MGSGYCVDYS TASRAGGSPS TGYRLTNFEP FNVRLVNDSV EPVGGLYEI QIPSEFTIGN FEEFIQTNSP KVTIDCAAFV CGDYAACREQ LVGYGSFCDN IEAILTEVND LLDTTQFQVA NSLMNGVTLS SRLKTGINF NVDDINFSSV LGCVGSDCNT VSSRSAIEDL LFNKVRLSDV GFVEAYNNCT GGAEIRDLLC VQTFNGIKVL P PVLSENQI SGYTLAATSA QLFPPWTAAA GIPFYLNVQY RINGLGVTMD VLSQNQKMIA NAFNNALGAI QNGFDPTNSA LV KIQAVVN ANAEALNNLL QQLSNRFGAI SSSLQEILSR LDPPEAQAQI DKLINGRLTA LNAFVSQQLS DTTLVKFSAS QAI EKVNEC VKSQSLRVNF CGNGNHIISL VQNAPYGLYF IHFNYVPTKY VTAKVSPGLC IAGDRGIAPK SGYFVNVNNM WMFT GSGYY YPEPITENNV VVMSTCAVNY TKAPDVMLNI LIPNLSDFKE ELDQWFKNQT SVAPDLSLDY INVTFLNLQD EMNRL QESI KVLNQSYINL KDKGTYEY |
-Macromolecule #3: 2-acetamido-2-deoxy-beta-D-glucopyranose
| Macromolecule | Name: 2-acetamido-2-deoxy-beta-D-glucopyranose / type: ligand / ID: 3 / Number of copies: 12 / Formula: NAG |
|---|---|
| Molecular weight | Theoretical: 221.208 Da |
| Chemical component information | ![]() ChemComp-NAG: |
-Macromolecule #4: Sapienic acid
| Macromolecule | Name: Sapienic acid / type: ligand / ID: 4 / Number of copies: 3 / Formula: 8Z9 |
|---|---|
| Molecular weight | Theoretical: 254.408 Da |
| Chemical component information | ![]() ChemComp-8Z9: |
-Experimental details
-Structure determination
| Method | cryo EM |
|---|---|
Processing | single particle reconstruction |
| Aggregation state | particle |
-
Sample preparation
| Concentration | 1.1 mg/mL | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Buffer | pH: 7.4 Component:
Details: 20 mM Tris-HCL, 150 mM NaCl, pH 7.4 | |||||||||
| Grid | Model: Quantifoil R1.2/1.3 / Material: COPPER / Mesh: 200 / Pretreatment - Type: GLOW DISCHARGE / Pretreatment - Time: 20 sec. | |||||||||
| Vitrification | Cryogen name: ETHANE / Chamber humidity: 100 % / Chamber temperature: 298 K / Instrument: FEI VITROBOT MARK IV |
-
Electron microscopy
| Microscope | TFS KRIOS |
|---|---|
| Specialist optics | Energy filter - Name: GIF Bioquantum / Energy filter - Slit width: 20 eV |
| Software | Name: EPU |
| Image recording | Film or detector model: GATAN K3 BIOQUANTUM (6k x 4k) / Average electron dose: 50.0 e/Å2 |
| Electron beam | Acceleration voltage: 300 kV / Electron source: FIELD EMISSION GUN |
| Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Nominal defocus max: 2.5 µm / Nominal defocus min: 1.0 µm / Nominal magnification: 105000 |
| Sample stage | Specimen holder model: FEI TITAN KRIOS AUTOGRID HOLDER |
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
+
Image processing
-Atomic model buiding 1
| Initial model | Chain - Source name: Other / Chain - Initial model type: in silico model / Details: ModelAngelo |
|---|---|
| Software | Name: UCSF ChimeraX (ver. 1.9) |
| Refinement | Protocol: OTHER |
| Output model | ![]() PDB-9r6t: |
Movie
Controller
About Yorodumi




Keywords
Equine coronavirus
Authors
Netherlands, 1 items
Citation


Z (Sec.)
Y (Row.)
X (Col.)




































Homo sapiens (human)

FIELD EMISSION GUN

